Target intelligence / Profile preview

Poly(A)-binding protein nuclear-like 1 (PABPN1L)

Target
PABPN1L
Molecular classification
RNA-binding protein, Maternal-effect gene, mRNA decay factor, Other
01

Overview

Poly(A)-binding protein nuclear-like 1 (PABPN1L) is a maternal-effect RNA-binding protein essential for normal oocyte maturation and early embryonic development[2][3][5]. PABPN1L binds the poly(A) tails of maternal mRNA in the oocyte cytoplasm, functioning as an adapter to recruit the BTG4–CCR4-NOT deadenylase complex, promoting deadenylation and degradation of a specific subset of maternal transcripts during the maternal-to-zygotic transition. PABPN1L is distinct from other poly(A)-binding proteins by its specific expression in oocytes and unique partner interactions necessary for early developmental processes. Loss of PABPN1L in mammals results in developmental arrest at the two-cell stage and female infertility due to impaired clearance of maternal mRNAs[2][3][4][5]. No drugs are known to interact with this target, and it is not established as a clinical biomarker or therapeutic target.

Other names
Embryonic polyadenylate-binding protein 2EPABP2PABPN1LPABPNL1Embryonic poly(A)-binding protein 2ePABP-2ePABP2Embryonic poly(A)-binding protein type IIPoly(A)-binding protein nuclear-like 1Poly(A) binding protein nuclear 1 like, cytoplasmic
02

Mechanism of action

Null.

03

Biological functions

mRNA stability and degradationAdapter functionOocyte maturation and embryo developmentOther
04

Disease associations

InfertilityOther
05

Safety considerations

Null.
06

Interacting drugs

None known.
07

Biomarkers

Null.

Beyond the preview

Go deeper on Poly(A)-binding protein nuclear-like 1 (PABPN1L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poly(A)-binding protein nuclear-like 1 (PABPN1L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call